Major paradigm shift incorporates five-year risk assessment and identifies increased-risk women beginning at age 35
The first clinical patient received a Clairity Breast cancer risk score, marking a historic milestone in women’s health. Clairity …
TIME’s Annual List Recognizes 100 of the World’s Most Influential Leaders in Health.
Clairity, a U.S.-based medical technology company advancing AI-powered breast cancer risk assessment, today announced that its founder, …
Clairity, developer of the first image-only AI model authorized by the U.S. Food and Drug Administration (FDA) that estimates a woman’s …
Actionable offering helps enable earlier, more personalized breast cancer interventions.
Clairity, Inc., an AI-driven precision health company pioneering image-based risk prediction, today announced the closing of a $43 …
During the broadcast, Dr. Connie Lehman shared a five-year breast cancer risk estimate for NBC anchor Savannah Sellers, generated from …
Clairity, Inc., a company pioneering AI-powered risk prediction in human health, today announced that Founder Dr. Connie Lehman has been …
Clairity Inc., a leader in AI-based breast cancer risk prediction, today announced that five scientific presentations featuring its …
